Show simple item record

dc.contributor.authorFlaum, N
dc.contributor.authorCrosbie, EJ
dc.contributor.authorWoodward, ER
dc.contributor.authorLalloo, F
dc.contributor.authorEvans, D Gareth R
dc.date.accessioned2020-01-29T15:17:48Z
dc.date.available2020-01-29T15:17:48Z
dc.date.issued2019en
dc.identifier.citationFlaum N, Crosbie EJ, Woodward ER, Lalloo F, Gareth Evans D. Challenging the believed proportion of ovarian cancer attributable to BRCA2 versus BRCA1 pathogenic variants. Eur J Cancer. 2020;124:88-90.en
dc.identifier.pmid31760313en
dc.identifier.doi10.1016/j.ejca.2019.10.018en
dc.identifier.urihttp://hdl.handle.net/10541/622663
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1016/j.ejca.2019.10.018en
dc.titleChallenging the believed proportion of ovarian cancer attributable to BRCA2 versus BRCA1 pathogenic variantsen
dc.typeArticleen
dc.contributor.departmentDivision of Evolution and Genomic Sciences, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, M13 9PLen
dc.identifier.journalEuropean journal of canceren
dc.description.noteen]
refterms.dateFOA2020-02-03T14:08:04Z


Files in this item

Thumbnail
Name:
31760313.pdf
Size:
296.8Kb
Format:
PDF
Description:
From UNPAYWALL

This item appears in the following Collection(s)

Show simple item record